Publications

Pharmacy in Glendale


Highlights of relevant published scholarly research work by our Nanomedicine COE-TCR members (indexed by year, since inception):

  1. D. Guzman-Villanueva, R. Q. Migrino, S. Truran, N. Karamanova, D. A. Franco, P. Hari, V. Weissig.  PEGylated-Nanoliposomal Clusterin for Amyloidogenic Light Chain-Induced Endothelial Dysfunction. J Liposome Res 2017, Jan 20:1-23. doi: 10.1080/08982104.2016.1274756. PubMed [citation] PMID:28103719 
  2. Rogers NM, Sharifi-Sanjani M, Yao M, Ghimire K, Bienes-Martinez R, Mutchler SM, Knupp HE, Baust J, Novelli EM, Ross M, St Croix C, Kutten JC, Czajka CA, Sembrat JC, Rojas M, Labrousse-Arias D, Bachman TN, Vanderpool RR, Zuckerbraun BS, Champion HC, Mora AL, Straub AC, Bilonick RA, Calzada MJ, Isenberg JS . TSP1-CD47 Signaling is Upregulated in Clinical Pulmonary Hypertension and Contributes to Pulmonary Arterial Vasculopathy and Dysfunction. Cardiovas Res (2017) Jan. 113: 15-29. doi: 10.1093/cvr/cvw218. PubMed [citation] PMID:27742621
  3. Weissig V. Liposomes came first. Methods Mol Biol. 2017;1522:1-15 doi:10.1007/978-1-4939-6591-5_1. PubMed [citation] PMID:27837526
  4. Joshi M, Park G, Pichlik J, Patel K. and Patel R. (2017) In vitro evaluation of bortezomib encapsulated in cationic and C6-ceramide liposomes, J Pharma Sci Pharmacol, 3, 1-9.

  1. Steuber N, Vo K, Wadhwa R, Birch J, Iacoban P, Chavez P, Elbayoumi TA. Tocotrienol Nanoemulsion Platform of Curcumin Elicit Elevated Apoptosis and Augmentation of Anticancer Efficacy against Breast and Ovarian Carcinomas. Int J Mol Sci. 2016 Oct;17(11):E1792. doi: 10.3390/ijms17111792. PubMed [citation] PMID:27792193
  2. Shen R, Kim JJ, Yao M, Elbayoumi TA. Development and evaluation of vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical. Int J Nanomedicine. 2016 Apr 26;11:1687-700. doi: 10.2147/IJN.S103332. eCollection 2016. PubMed [citation] PMID: 27217747
  3. Pham J, Nayel A, Hoang C, Elbayoumi TA. Enhanced effectiveness of tocotrienol-based nano-emulsified system for topical delivery against skin carcinomas. Drug Deliv. 2016 Jun;23(5):1514-24. doi: 10.3109/10717544.2014.966925. PubMed [citation] PMID: 25293973
  4. Elbayoumi TA. Editorial: Lipidic Nano-carrier Delivery of "Big" Molecules. Curr Pharm Biotechnol. 2016;17(8):661. PubMed [citation] PMID: 27215370
  5. Hull EE, Montgomery MR, Leyva KJ. HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases. Biomed Res Int. 2016;2016:8797206. doi: 10.1155/2016/8797206. PubMed [citation] PMID: 27556043
  6. Davis MR, Daggett JJ, Pascual AS, Lam JM, Leyva KJ, Cooper KE, Hull EE. Epigenetically maintained SW13+ and SW13- subtypes have different oncogenic potential and convert with HDAC1 inhibition. BMC Cancer. 2016 May 17;16:316. doi: 10.1186/s12885-016-2353-7. PubMed [citation] PMID: 27188282
  7. Joshi M, Oesterling B., Wu C., Gwizdz N., Pais G., Briyal S. and Gulati A. (2016) Evaluation of liposomal nanocarriers loaded with ETB receptor agonist, IRL-1620, using cell based assays, Neuroscience. 312, 141-152.
  8. Joshi M (2016) Interviewed for "Life Science Avenues and Opportunities" (LSAO), A complete guide to step up the life science career ladder in the Inspiring Role Models in the Life Sciences Sector.
  9. Joshi M, (2016) Nanomedicines for treatment of stroke-Opinion Article, Int J Nanomed Nanosurgery. 2(3).
  10. Yao M, Sturdivant J, Elbayoumi TA. Novel Pharmaceutical Strategy for Selective Abrogation of Thrombospondin 1-Induced Vascular Dysfunctions via Decoy recombinant CD47. The FASEB J. 2016 April;30(1):Supl.1201.3
  11. Rogers NM, Sharifi-Sanjani M, Yao M, Ghimire K, Bienes-Martinez R, et al. TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction. Cardiovasc Res. 2016 Oct;23(5):1514-24. doi:10.1093/cvr/cvw218. PubMed [citation] PMID: 27742621
  12. Valekunja RB, Kamakoti V, Peter A, Phadnis A, Prasad S, and Nagaraj VJ. The Detection of Papaya Ringspot Virus Coat Protein Using an Electrochemical Immunosensor. Anal Methods. 2016 (in press)
  13. J.P. Hegarty, J. Krzeminski, A.K. Sharma, D. Guzman-Villanueva, V. Weissig, D.B. Stewart. Bolaamphiphile-based Nanocomplex Delivery of Phosphorothioate Gapmer Antisense Oligonucleotides as a Treatment for Clostridium difficile. Int J Nanomedicine. 2016:11, 3607-3619. doi: 10.2147/IJN.S109600. PubMed [citation] PMID:27536102
  14. Franco, D.A., Truran, S., Weissig, V., Guzman-Villanueva, D., Senapati, S., Karamanova, N. Burciu, C., Ramirez-Alvarado, M., Lindsay, S., Hari, P., and Migrino, R.Q. Monosialoganglioside-containing Nanoliposomes restore endothelial function impaired by AL Amyloid Light Chain Proteins. J Am Heart Assoc. 2016 Aug 1;11:3607-19 doi: 10.1161/JAHA.116.003318. PubMed [citation] PMID:27412900
  15. S. Truran, V. Weissig, J. Madine, H. Davies, D. Guzman-Villanueva, D. A. Franco, C. Burciu, N. Karamanova, Serrano, G., Beach, T.G., R. Q. Migrino. Nanoliposomes Protect against Human Arteriole Endothelial Dysfunction Induced by β-amyloid Peptide, J Cerebral Blood Flow & Metabolism. 2016 Feb;36(2):405-12. doi:10.1177/0271678X15610134. PubMed [citation] PMID: 26661197

Nanoscale Medicine, Biology, and Pharmaceutical Books authored by our Nanomedicine COE-TCR members (indexed by year):



  1. A. Prokop, V. Weissig (Editors): Intracellular Delivery III, Fundamentals and Applications. (2017) Springer, Dordrecht, Heidelberg, New York, London. [Link]
  2. V. Weissig, M. Edeas (Editors): Mitochondrial Medicine: Methods and Protocols. Volume 1: Probing mitochondrial function. (2015) Springer Protocol Series "Methods in Molecular Biology", The Humana Press Inc., Totowa, NJ, USA. [Link]
  3. V. Weissig, M. Edeas (Editors): Mitochondrial Medicine: Methods and Protocols. Volume 2: Manipulating mitochondrial function. (2015) Springer Protocol Series "Methods in Molecular Biology", The Humana Press Inc., Totowa, NJ, USA. [Link]
  4. V. Weissig, T. Elbayoumi, M Olsen (Editors): Cellular and Subcellular Nanotechnology: Methods and Protocols. Springer Protocol Series "Methods in Molecular Biology", MiMB Series No 991 (2013). 32 chapters, 370 pages, The Humana Press Inc., Totowa, NJ, USA. [Link]
  5. V. Weissig and G. GM D'Souza (Editors): Organelle-specific Pharmaceutical Nanotechnology (2010). 27 chapters, 590 pages. John Wiley & Sons, Inc., New York. [Link]
  6. V. Weissig (Editor): Liposomes. Methods and Protocols. Volume 1: Pharmaceutical Nanocarriers. Springer Protocol Series "Methods in Molecular Biology", Volume 605" (2010). 36 chapters, 563 pages. The Humana Press Inc., Totowa, NJ, USA. [Link]
  7. V. Weissig (Editor): Liposomes. Methods and Protocols. Volume 2: Biological Membrane Models. Springer Protocol Series "Methods in Molecular Biology", Volume 606" (2010). 36 chapters, 548 pages. The Humana Press Inc., Totowa, NJ, USA. [Link]